Evidence map›Paper›PMID 30006744›Full record

ArticleDer Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen2019

[Speech therapy after thyroid gland operations in Germany: analysis of routine data from 50,676 AOK patients].

M Maneck, C Dotzenrath, H Dralle, C Fahlenbrach, R Paschke, T Steinmüller, E Tusch, E Jeschke, C Günster

Abstract read
PubMed Publisher
In one paragraph

Article in Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Observational
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 1 country.

M ManeckWissenschaftliches Institut der AOK, Rosenthaler Str. 31, 10178, Berlin, Deutschland. Matthias.Maneck@wido.bv.aok.de.
C DotzenrathKlinik für Endokrine Chirurgie, Helios Universitätsklinikum Wuppertal, Wuppertal, Deutschland.
H DralleKlinik für Allgemein‑, Viszeral- und Transplantationschirurgie, Universitätsklinikum Essen, Essen, Deutschland.
C FahlenbrachAOK-Bundesverband, Berlin, Deutschland.
R PaschkeKlinik für Endokrinologie und Nephrologie, Universität Leipzig, Leipzig, Deutschland.
T SteinmüllerZentrum für Endokrine Chirurgie, DRK Kliniken Berlin/Westend, Berlin, Deutschland.
E TuschMedizinischer Dienst der Krankenversicherung Berlin-Brandenburg, Berlin, Deutschland.
E JeschkeWissenschaftliches Institut der AOK, Rosenthaler Str. 31, 10178, Berlin, Deutschland.
C GünsterWissenschaftliches Institut der AOK, Rosenthaler Str. 31, 10178, Berlin, Deutschland.
Wissenschaftliches Institut der AOK · DEBundesverband Glaukom-Selbsthilfe · DEDRK Kliniken Berlin · DEGerman Society of Medical Intensive Care and Emergency Medicine · DEHelios Universitätsklinikum Wuppertal · DELeipzig University · DERuhrlandklinik · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study investigated the frequency of postoperative speech therapy in the context of vocal cord palsy after thyroid surgery based on nationwide routine data. Additionally, volume-outcome relationships were examined. MATERIAL AND

methodsNationwide routine data from insured patients of the Local Health Insurance Fund (AOK) who underwent thyroid surgery for a benign thyroid disease between 2013 and 2015 were analyzed. Postoperative speech therapy was determined based on prescription data. Transient and permanent vocal cord palsy were determined using indicators. The effect of hospital volumes (volume quintiles) on prescription of postoperative speech therapy was determined by multivariate logistic regression.

resultsA total of 50,676 thyroid gland operations were identified. The overall frequency of postoperative speech therapy prescription was 6.5%. In AOK patients with transient or permanent vocal cord palsy, the frequencies of postoperative speech therapy prescription were 56.1% and 75.2%, respectively. The prescription volume of the normal case (≥21 units of speech therapy) was exceeded in 0.7% of the AOK patients. In the two lowest case volume categories the risk of postoperative speech therapy exceeding the prescription volume of the normal case was significantly higher compared to the highest case volume hospitals (odds ratios: 1.2 and 1.8, respectively).

conclusionThis study presents the reality of healthcare with respect to the frequency of speech therapy prescription after thyroid gland surgery in Germany. In addition, it was determined that the risk of postoperative speech therapy prescription exceeding the volume of the normal case after thyroid gland operations decreases with increasing case volumes of hospitals.

Indexed as

Speech TherapyThyroid DiseasesVocal Cord ParalysisGermanyHumansPostoperative ComplicationsThyroidectomyBenign strumaRoutine dataSpeech therapyThyroid gland operationVolume outcome

Identifiers

PMID30006744
OpenAlexW2884428071

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.